MedTrace Logo

Observational Study of Survival Outcomes of Stage IV Cancer Patients

NCT01843985 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 120

Last updated 2013-05-01

No results posted yet for this study

Summary

Patients diagnosed with Stage IV cancer (solid tumors only) are evaluated to determine whether they are candidates for traditional chemotherapy. If eligible, patients are offered traditional chemotherapy, low-dose chemotherapy, or palliative care. If ineligible, patients are offered low-dose chemotherapy or palliative care. Patients will be monitored for 5 years and survival data recorded.

Conditions

  • Stage IV Cancer (Solid Tumors Only)
  • Survival

Sponsors & Collaborators

  • Cure Cancer Worldwide Corporation

    lead INDUSTRY

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-06-30
Primary Completion
2018-12-31
Completion
2018-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01843985 on ClinicalTrials.gov